M8 Pharmaceuticals, an Acino company ('M8') announces that the company has signed an exclusive licensing agreement with Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN) ('Supernus'), a biopharmaceutical ...

The UAE's reputation as an innovation center is well-earned. It is to these shores, more than any other in the region, that ...

And these investments need not necessarily be greenfield developments. For example, Acino’s UAE-based state-of-the-art production capabilities open the door to closing the medicine security gap.

The UK subsidiary of Japanese pharma major Takeda has received approval from the Medicines and Healthcare Products Regulatory Agency (MHRA) for lanadelumab (trademarked Takhzyro) for the routine ...